UBS Maintains Neutral on CryoPort, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
UBS analyst John Sourbeer has maintained a Neutral rating on CryoPort (NASDAQ:CYRX) and increased the price target from $14.5 to $17.
March 15, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS has maintained a Neutral rating on CryoPort, but raised the price target from $14.5 to $17.
The increase in price target by UBS suggests a positive outlook on CryoPort's future performance, potentially leading to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100